Trial intelligence / Profile preview

Evacuatio Uteri or Conservtive Treatment After Late Abortion

NCT00256009Phase 4Unknown

Sponsor
Rigshospitalet
Modality
Small Molecules
01

Overview

Phase 4, randomised, open-label trial of misoprostol in abortion (2 arms), sponsored by Rigshospitalet. Primary endpoints: Side-effects and Complications. Status: unknown.

02

Drugs

misoprostol
03

Conditions

abortion

Beyond the preview

Go deeper on NCT00256009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00256009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call